These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12468677)

  • 1. Case-reporting of acute hepatitis B and C among injection drug users.
    Hagan H; Snyder N; Hough E; Yu T; McKeirnan S; Boase J; Duchin J
    J Urban Health; 2002 Dec; 79(4):579-85. PubMed ID: 12468677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of serologic markers of HBV, HDV, HCV and HIV in non-injection drug users compared to injection drug users in Gran Canaria, Spain.
    Santana Rodríguez OE; Malé Gil ML; HernándezSantana JF; Limiñana Cañal JM; Martín Sánchez AM
    Eur J Epidemiol; 1998 Sep; 14(6):555-61. PubMed ID: 9794122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews.
    Nelson PK; Mathers BM; Cowie B; Hagan H; Des Jarlais D; Horyniak D; Degenhardt L
    Lancet; 2011 Aug; 378(9791):571-83. PubMed ID: 21802134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004.
    Burt RD; Hagan H; Garfein RS; Sabin K; Weinbaum C; Thiede H
    J Urban Health; 2007 May; 84(3):436-54. PubMed ID: 17356901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales.
    Sutton AJ; Gay NJ; Edmunds WJ; Hope VD; Gill ON; Hickman M
    BMC Infect Dis; 2006 Jun; 6():93. PubMed ID: 16762050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risks for HIV, HBV, and HCV infections among male injection drug users in northern Vietnam: a case-control study.
    Quan VM; Go VF; Nam le V; Bergenstrom A; Thuoc NP; Zenilman J; Latkin C; Celentano DD
    AIDS Care; 2009 Jan; 21(1):7-16. PubMed ID: 19085215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B, C, and D virus infection showing distinct patterns between injection drug users and the general population.
    Chen F; Zhang J; Guo F; Wen B; Luo S; Yuan D; Lin Y; Ou W; Tang P; Dai G; Li F; Liu W; Qu X
    J Gastroenterol Hepatol; 2017 Feb; 32(2):515-520. PubMed ID: 27248508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syringe exchange and risk of infection with hepatitis B and C viruses.
    Hagan H; McGough JP; Thiede H; Weiss NS; Hopkins S; Alexander ER
    Am J Epidemiol; 1999 Feb; 149(3):203-13. PubMed ID: 9927214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance for acute viral hepatitis - United States, 2007.
    Daniels D; Grytdal S; Wasley A;
    MMWR Surveill Summ; 2009 May; 58(3):1-27. PubMed ID: 19478727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changing epidemiology and viral interplay of hepatitis B, C and D among injecting drug user-dominant prisoners in Taiwan.
    Lu MY; Chen CT; Shih YL; Tsai PC; Hsieh MH; Huang CF; Yeh ML; Huang CI; Wang SC; Tsai YS; Ko YM; Lin CC; Chen KY; Wei YJ; Hsu PY; Hsu CT; Jang TY; Liu TW; Liang PC; Hsieh MY; Lin ZY; Chen SC; Huang JF; Dai CY; Chuang WL; Yu ML; Chang WY
    Sci Rep; 2021 Apr; 11(1):8554. PubMed ID: 33879825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A hepatitis A, B, C and HIV prevalence and risk factor study in ever injecting and non-injecting drug users in Luxembourg associated with HAV and HBV immunisations.
    Removille N; Origer A; Couffignal S; Vaillant M; Schmit JC; Lair ML
    BMC Public Health; 2011 May; 11():351. PubMed ID: 21595969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study on the blood-borne virus co-infection and T lymphocyte subset among intravenous drug users.
    Li JR; Gong RY; Tian KL; Wang J; Wang YX; Huang HJ
    World J Gastroenterol; 2007 Apr; 13(16):2357-62. PubMed ID: 17511038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surveillance of HIV, hepatitis B virus, and hepatitis C virus in an estonian injection drug-using population: sensitivity and specificity of testing syringes for public health surveillance.
    Uuskula A; Heimer R; Dehovitz J; Fischer K; McNutt LA
    J Infect Dis; 2006 Feb; 193(3):455-7. PubMed ID: 16388495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.
    Devi KhS; Brajachand N; Singh HL; Singh YM
    J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran, Iran.
    Rahimi-Movaghar A; Razaghi EM; Sahimi-Izadian E; Amin-Esmaeili M
    Int J Infect Dis; 2010 Jan; 14(1):e28-33. PubMed ID: 19464218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prevalence of HIV, HIV/hepatitis C virus coinfection, and risk behaviors among injection drug users in Chennai, India: a cause for concern.
    Solomon SS; Srikrishnan AK; Mehta SH; Vasudevan CK; Murugavel KG; Thamburaj E; Anand S; Kumar MS; Latkin C; Solomon S; Celentano DD
    J Acquir Immune Defic Syndr; 2008 Nov; 49(3):327-32. PubMed ID: 18845962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A longitudinal study on the incidence and transmission patterns of HIV, HBV and HCV infection among drug users in Amsterdam.
    Van Ameijden EJ; Van den Hoek JA; Mientjes GH; Coutinho RA
    Eur J Epidemiol; 1993 May; 9(3):255-62. PubMed ID: 8405310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population-based prevalence of hepatitis B and C virus, HIV, syphilis, gonorrhoea and chlamydia in male injection drug users in Lagos, Nigeria.
    Tun W; Vu L; Adebajo SB; Abiodun L; Sheehy M; Karlyn A; Njab J; Ahonsi B; Issa BK; Idogho O
    Int J STD AIDS; 2013 Aug; 24(8):619-25. PubMed ID: 23970571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of HIV, hepatitis B and hepatitis C and associated risk behaviours amongst injecting drug users in three Afghan cities.
    Nasir A; Todd CS; Stanekzai MR; Bautista CT; Botros BA; Scott PT; Strathdee SA; Tjaden J
    Int J Drug Policy; 2011 Mar; 22(2):145-52. PubMed ID: 21146392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of Hepatitis B and C among Drug-Abusing Male Prisoners in Birjand, South Khorasan, Iran.
    Ghafari S; Sharifzadeh G; Jamali S; Taji B; Javadmoosavi SY; Ziaee M
    Arch Iran Med; 2019 Sep; 22(9):501-504. PubMed ID: 31679371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.